Investors

Insider Transactions

Date Name Title Sorted Ascending Type Shares Traded Price Range
Feb 20, 2009 baker charles a Director Automatic Sell 10,000 18.16
Feb 20, 2009 baker charles a Director Option Execute 10,000 7.66
Jun 2, 2010 baker charles a Director Option Execute 5,000 25.43
Jul 1, 2011 baker charles a Director Automatic Sell 11,000 55.94 - 57.40
Mar 24, 2014 baker charles a Director Option Execute 15,000 23.84
Jun 10, 2013 baker charles a Director Automatic Sell 15,000 250.06 - 257.99
Jun 10, 2013 baker charles a Director Option Execute 15,000 15.80
Sep 30, 2013 baker charles a Director Automatic Sell 15,000 302.46 - 319.13
Sep 30, 2013 baker charles a Director Option Execute 15,000 19.69
Nov 26, 2013 baker charles a Director Disposition (Non Open Market) 590 n/a
Mar 24, 2014 baker charles a Director Automatic Sell 15,000 300.09 - 313.40
Sep 5, 2012 baker charles a Director Automatic Sell 1,286 150.00
Sep 6, 2012 baker charles a Director Automatic Sell 13,714 150.00
Sep 5, 2012 baker charles a Director Option Execute 1,286 15.01
Sep 6, 2012 baker charles a Director Option Execute 13,714 15.01
Nov 26, 2012 baker charles a Director Automatic Sell 15,000 171.45 - 175.14
Nov 26, 2012 baker charles a Director Option Execute 15,000 9.17
Jul 1, 2011 baker charles a Director Option Execute 11,000 28.81
Aug 10, 2011 baker charles a Director Option Execute 4,000 28.81
Apr 17, 2012 baker charles a Director Automatic Sell 2,090 125.00
Showing 41-60 of 829 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)